BWX Technologies, Inc.: Initiation Of Coverage – Microreactor Development and Deployment, Medical Isotopes & Other Crucial Growth Levers! 

BWX Technologies reported robust achievements in the second quarter of 2024, surpassing expectations with organic revenue growth of 11%, adjusted EBITDA growth of 18%, and a 26% increase in adjusted earnings per share. These encouraging developments stem from proficient executions across business lines and favorable timing in the first half, prompting the company to raise the lower end of its adjusted earnings per share guidance to a new range of $3.10 to $3.20 and to reaffirm expectations for mid-single-digit growth in both revenue and adjusted EBITDA for the full year.